A pair of companies have gotten the go-ahead for human trials of a zika virus vaccination, they have announced. Inovio Pharmaceuticals and GeneOne Life Science got approval for a phase I trial, which will concern Inovio's Zika DNA vaccine GLS-5700. The vaccination is designed to prevent zika virus infections in humans; it showed promise in pre-clinical trials involving both small …
A pair of companies have gotten the go-ahead for human trials of a zika virus vaccination, they have announced. Inovio Pharmaceuticals and GeneOne Life Science got approval for a phase I trial, which will concern Inovio's Zika DNA vaccine GLS-5700. The vaccination is designed to prevent zika virus infections in humans; it showed promise in pre-clinical trials involving both small …
Share this Article
Recommended